
Conference Coverage
Latest Content

Total Neoadjuvant Therapy May Aid Organ Preservation in Early Rectal Cancer

Stronger Carer-Child Bonds Don’t Predict Later Mental Health

Cefdinir Nearly Doubles Outpatient Uncomplicated UTI Treatment Failure Compared With Cephalexin

What Patients Are Really Telling Us About the Use of AI

Five Ways AI Is Transforming Cancer Care—and Companies That Are Making It Happen

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

A Stakeholder Interchange convened in Los Angeles, California, by The American Journal of Managed Care explores the treatment landscape for relapsed/refractory multiple myeloma, focusing on the challenges of bringing bispecific antibodies to patients in an outpatient setting.

Utilizing the Health Insurance Disparities Index for assessment, the authors found that New York’s Medicaid health maintenance organizations (HMOs) outperformed Medicaid HMOs nationally in addressing health care disparities from 2019 to 2023.

HHS has initiated removal of black box warnings on hormone replacement therapy, citing its advantages to women's health, but also drawing pushback.

The trial did not meet its primary end point for reducing plaque progression.

New findings reveal high rates of depression, anxiety, and sleep issues in individuals with psoriatic arthritis and palmoplantar psoriasis.

In this investigation, the authors evaluated the impact of a voluntary transition to risk-based contracts under Medicare Advantage on health care use.

A white paper explores how biomarker testing enhances patient outcomes and what barriers prevent access several common cancers.

Delgocitinib has emerged as a promising treatment for CHE, addressing unmet needs and enhancing understanding of this complex condition, notes Raj Chovatiya, MD, PhD, MSCI.

Higher dietary fiber intake was associated with a reduced risk of moderate to severe diarrhea up to 2 years after diagnosis.

Combining 3 standard therapies into a single pill improved outcomes for adults with heart failure with reduced ejection fraction.































































